Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
⚠️ Important: Screen for thiopurine methyltransferase (TPMT) deficiency before starting therapy. TPMT is an enzyme that metabolises azathioprine — about 1 in 300 patients have very low activity, predisposing to severe toxicity. Patients should be warned to report immediately any signs of bone marrow suppression (e.g. unexplained bruising, bleeding, sore throat, infection).
| Indication | Details |
|---|---|
| 🩺 Transplant rejection prophylaxis |
• 1–2.5 mg/kg/day PO
• Adjust to response/tolerability |
| 🧬 Autoimmune diseases |
• 1–3 mg/kg/day PO
• Withdraw if no response after 3 months |
| 💩 Inflammatory bowel disease (IBD) |
• 2–2.5 mg/kg/day PO (normal TPMT activity)
• ⚠️ Start at ~50% target dose for first week to reduce side effects |
| 💉 IV Azathioprine |
• Strongly irritant
• Only if oral route not feasible |